Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


Future of NZ's clinical research under microscope

Future of New Zealand's clinical research under the microscope

GlaxoSmithKline is launching what it hopes will only be the start of annual clinical research forums in New Zealand.

The inaugural National Clinical Trials Seminar is being held on Saturday 1 November at the Heritage Hotel, Hobson Street, Auckland, from 9am to 4pm.

Topics will include the trans-Tasman agreement, the role of DHBs in clinical research, Maori consultation, ethics committees, indemnity and compensation.

"The symposium is open to anybody with an interest in clinical research including clinicians, research nurses, general nurses and the pharmaceutical industry," GlaxoSmithKline medical director Dr Ian Griffiths says.

The idea for a New Zealand clinical research forum came from GSK's clinical research team. The team attended the Australian Clinical Research Symposium last year and found the experience extremely valuable. It also sparked the idea to hold a similar event here celebrating New Zealand research.

GlaxoSmithKline invests the equivalent of NZ $8 billion annually in clinical research around the world and in addition to being involved with the international research GSK New Zealand has also invested $8 million in clinical research right here. This research includes asthma, looking at the effects of the company's latest type 2 diabetes medication on cardiovascular disease in type 2 diabetes patients, research looking at combination treatment for chronic obstructive pulmonary disease (COPD) and studies looking at the prevention of prostate cancer and treatment of atrial fibrillation.

It is for this reason the clinical research team believes an annual symposium will provide a valuable and exciting platform for New Zealand's clinical researchers to come together, Dr Griffiths says. "The company believes this is an important enough initiative to take a lead and organise the first event. However, it is hoped others will take on the organisation of future forums, and that the forums will become an annual event."

The deadline for registration is the end of September. Registration forms can be accessed on the GlaxoSmithKline website

© Scoop Media

Business Headlines | Sci-Tech Headlines


Stats NZ: Consents For New Homes At All-Time High

A record 41,028 new homes have been consented in the year ended March 2021, Stats NZ said today. The previous record for the annual number of new homes consented was 40,025 in the year ended February 1974. “Within 10 years the number of new homes ... More>>

Stats NZ: Unemployment Declines As Underutilisation Rises

The seasonally adjusted unemployment rate decreased to 4.7 percent in the March 2021 quarter, continuing to fall from its recent peak of 5.2 percent in the September 2020 quarter but remaining high compared with recent years, Stats NZ said today. ... More>>


Digitl: The Story Behind Vodafone’s FibreX Court Ruling

Vodafone’s FibreX service was in the news this week. What is the story behind the Fair Trading Act court case? More>>

Reserve Bank: Concerned About New Zealand's Rising House Prices

New Zealand house prices have risen significantly in the past 12 months. This has raised concerns at the Reserve Bank of New Zealand – Te Putea Matua about the risk this poses to financial stability. Central banks responded swiftly to the global ... More>>

Westpac: Announces Strong Financial Result

Westpac New Zealand (Westpac NZ) [i] says a strong half-year financial result has been driven by better than expected economic conditions. Chief Executive David McLean said while the global COVID-19 pandemic was far from over, the financial effect on ... More>>

MYOB: SME Confidence In Economic Performance Still Cautious

New insights from the annual MYOB Business Monitor have shown the SME sector is still cautious about the potential for further economic recovery, with two-in-five (41%) expecting the New Zealand economy to decline this year. The latest research ... More>>